PKO Investment Management Joint-Stock Co
Position in ALNY — Alnylam Pharmaceuticals, Inc.
CIK 2059321
WARSAW, R9
Position in ALNY
as of Jun 30, 2026
· filed Jul 20, 2026
Position Value
$2,257,725
+$7,809 QoQ
Shares Held
7,500
+10.3% QoQ
Ownership
0.006%
of shares outstanding
% of Portfolio
0.20%
of 13F equity value
Holder Rank
#318
of 780 holders
Holding Since
Sep 2025
4 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ALNY Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026PKO Investment Management Joint-Stock Co holds $12,619,311 across 6 Biotechnology names. ALNY ranks #3 (17.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
11,050 | $5,488,866 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
5,900 | $3,678,886 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
This page
|
7,500 | $2,257,725 | |
| 4 | INSM |
INSMED Inc
|
5,100 | $543,762 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
2,200 | $412,016 | |
| 6 | INCY |
Incyte Corp
|
2,100 | $238,056 |
All Filings in ALNY
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,257,725 | 7,500 | Shares | Sole | 2026-07-20 | |
| 2026-03-31 | $2,249,916 | 6,800 | Shares | Sole | 2026-04-17 | |
| 2025-12-31 | $2,704,020 | 6,800 | Shares | Sole | 2026-02-02 | |
| 2025-09-30 | $364,800 | 800 | Shares | Sole | 2025-10-27 | |
| No filing history on record for this holder in this stock. | ||||||